MITOMYCIN - 10 YEARS AFTER APPROVAL FOR MARKETING

被引:107
作者
DOLL, DC
WEISS, RB
ISSELL, BF
机构
[1] WALTER REED ARMY MED CTR,MED ONCOL SECT,WASHINGTON,DC 20012
[2] UNIFORMED SERV UNIV HLTH SCI,BETHESDA,MD 20814
[3] BRISTOL MYERS CO LABS,SYRACUSE,NY 13201
[4] SUNY UPSTATE MED CTR,SYRACUSE,NY 13210
关键词
D O I
10.1200/JCO.1985.3.2.276
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:276 / 286
页数:11
相关论文
共 147 条
[21]   MITOMYCIN-C - REVIEW [J].
CROOKE, ST ;
BRADNER, WT .
CANCER TREATMENT REVIEWS, 1976, 3 (03) :121-139
[22]  
CROOKE ST, 1976, CANCER TREAT REP, V60, P1633
[23]  
DABROWIAK JC, 1982, ADV INORG BIOCH, V4, P66
[24]  
DENHARTIGH J, 1983, CANCER RES, V43, P5017
[25]   CHEMOTHERAPEUTIC-AGENTS AND THE ERYTHRON [J].
DOLL, DC ;
WEISS, RB .
CANCER TREATMENT REVIEWS, 1983, 10 (03) :185-200
[26]  
DOROSHOW JH, 1981, J PHARMACOL EXP THER, V218, P206
[27]   AN INTERIM-REPORT OF A PROSPECTIVE, RANDOMIZED, CONTROLLED-STUDY OF ADJUVANT CHEMOTHERAPY IN OPERABLE GASTRIC-CANCER - BRITISH STOMACH-CANCER GROUP [J].
FIELDING, JWL ;
FAGG, SL ;
JONES, BG ;
ELLIS, D ;
HOCKEY, MS ;
MINAWA, A ;
BROOKES, VS ;
CRAVEN, JL ;
MASON, MC ;
TIMOTHY, A ;
WATERHOUSE, JAH ;
WRIGLEY, PFM .
WORLD JOURNAL OF SURGERY, 1983, 7 (03) :390-399
[28]  
FLAM MS, 1983, CANCER, V51, P1378, DOI 10.1002/1097-0142(19830415)51:8<1378::AID-CNCR2820510810>3.0.CO
[29]  
2-F
[30]  
FRANK W, 1960, CANCER CHEMOTH REP, V9, P114